India, July 9 -- Today's top biotech gainers include Virax Biolabs, following its agreement with Fosun Diagnostics; Forte Biosciences, after reporting positive vitiligo data; Connect Biopharma, with a key near-term catalyst ahead; and SANUWAVE Health, despite recently lowering its second-quarter guidance, among others.
Read on.
Virax Soars on Fosun Deal
Virax Biolabs Group Ltd. (VRAX), a biotechnology company that develops tests to measure immune responses and analyze T cells, was among Thursday's top-performing stocks, with its shares surging more than 100%.
The rally followed the announcement that its wholly owned subsidiary, Virax Biolabs (UK) Limited, had signed an exclusive multi-country commercial supply agreement with Fosun Diagn...